FDA Investigator Sean R Bryd
Sean R Bryd has inspections in 6 countries as of 29 Sep 2023. Sean R Bryd has collaborated with a combinined 3506 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Belgium,
United States of America,
France,
Italy,
Canada,
Hungary
Co-Investigator(s):
Anissa M Cheung,
Anita Verma,
Ann L Demarco,
Ann Marie Montemurro,
Arduino Frankovic,
Ashley L Reiber,
Ava M Bowman,
Barbara M Frazier,
Benjamin J Smith,
Bradley Dworak, PhD,
Brentley S Collins,
Brian D Nicholson,
Burnell M Henry,
Carrie Ann Plucinski,
Cassandra Overking,
CDR Donald Ertel,
CDR Jeremy L Wally, PhD,
Chad R Burger,
Charles M Spyr,
Cheng H Yen,
Christian D Lynch (CDL),
Christina D Lynch,
Christina J Sauder, PhD,
Christine A Harman, PhD,
Claire M Minden,
Constantin Y Philopoulos,
Cristina Ausin Moreno, PhD,
Cristina Ausin Moreoo, PhD,
Cynthia Jim, CSO,
Daniel C Kearns,
Darla J Christopher,
Daryl A Dewoskin,
David A Paterson,
David Perkins,
Deborah J Parris,
Deborah M Trout,
Debra I Love,
Devaughn Edwards,
Diana Kouiavskaia,
Diane L Raccasi,
Dino Feigelstock (DF), PhD,
Dmitriy V Volokhov, PhD,
Donald L Lech,
Dr. Andrew Shroke,
Dr. Gang Wang, PhD,
Eboni S Funderburk,
Edmund F Mrak, Jr,
Edwin Jao,
Eileen A Liu,
Eliezar Ramos,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Enrico Joset Mangahis,
Eric Peng,
Esther C Broner, PhD,
Gene D Arcy,
Gregory Price,
Haruhiko Murata,
Hector A Carrero,
Helen B Ricalde,
Humera Khan,
Humera T Khan,
Hyesuk Kong,
Hyung Yul Lee,
Ifueko Osemwota,
J David Doleski,
Jacqueline Mdiaz Albertini,
James A Lane,
James C Maclaughlin,
James E Keller, PhD,
James L Kenney, DSc,
James M Simpson,
James R Evans,
James T Mccoy,
Jaqueline Diaz Albertini,
Jason F Chancey,
Jeanne M Morris,
Jeffrey A Sommers,
Jeffrey D Meng,
Jennifer L Bridgewater,
Jennifer L Schmidt,
Joan A Loreng,
Joan Johnson,
John F Cipollo,
John M Mcinnis,
John M Seale,
John P Mistler,
Jon P Antoniou,
Joseph George,
Joslyn K Brunelle, PhD,
Jude C Dikes,
Julie D Bringger,
Jun Park, PhD,
Kevin P Foley,
Kirsten L Vadheim, PhD,
Kristina J Donohue,
Kula N Jha,
Larry K Austin,
Laura Fontan, MS,
Laurel A Beer,
Laurie P Norwood,
LCDR Debra Emerson,
LCDR Randall L Morris,
LCDR Sean Byrd,
Leslie D Wagner,
Lewis K Antwi,
Linda Thai,
Logan T Williams,
Lori P Peters,
Lori S Lawless,
Marc S Neubauer,
Maria Cruz Fisher,
Maria I Cruz Fisher,
Marian Majors,
Mariza M Jafary,
Martha T Olone,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Michele Perry Williams,
Mihaly S Ligmond,
Muna Algharibeh,
Muna Alghribeh,
Nancy T Waites,
Nawab A Siddiqui,
Nicholas L Paulin,
Nicole K Trudel,
Olno Folgolstock,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patricia A Morrow,
Patricia Fhughes Troost,
Patsy J Domingo,
Paul W Keller,
Paula A Trost,
Peng Zhou,
Pote Amin,
Prabhu P Raju,
Priscilla M Pastrana,
Qing Joanna Zhou, PhD,
Rabia Ballica, PhD,
Ralph A Erickson,
Rebecca E Dombrowski,
Rebecca K Olin,
Regina Gibson Melton,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Richard T Riggie,
Robert Barbosa,
Robert C Coleman,
Robert M Barbosa,
Robert W Jennings,
Robin Levis, PhD,
Roger F Zabinski,
Rona A Leblanc,
Ronald E Lundquist,
Ronald T Nowalk,
Rose M Ashley,
Russell K Riley,
Samuel W Labinjo,
Sandra A Boyd,
Sarah B Tanksley,
Sarah M Meng,
Sarah M Napier,
Sargum C Sood,
Scott E Norris,
Scott R Nichols, PhD,
Scott T Ballard,
Shuang Tang,
Sidney B Priesmeyer,
Simone E Pitts,
Sneha S Patel,
Stacey S Degarmo,
Stephen D Brown,
Steven C Derrick,
Steven P Donald,
Susan M Jackson,
Susan P Bruederle,
Susan Yu,
Tim S Roecklein,
Timothy J Schmidt,
Tina Buecklein,
Tina S Roecklein,
Travis S Bradley,
Troy C Quander,
Unnee Ranjan,
Vaishali J Patel,
Wayne E Seifert,
Wei Wang, PhD,
Yanming An, PhD,
Yonggang Wang, PhD,
Zhihao Qiu (Peter), PhD
Sean R Bryd's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2008 | FDA 483 | Sanofi Pasteur Limited - Form 483, 2008-07-24 |
| July, 2008 | EIR | Sanofi Pasteur Limited - EIR, 2008-07-24 |
| February, 2012 | EIR | Catalent Indiana, LLC - EIR, 2012-02-24 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more